
Overview
My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shortening were first identified in the context of dyskeratosis congenita, a premature aging syndrome that predisposes to cancer. Dyskeratosis congenita patients and patients with telomere-mediated syndromes have an increased risk for developing certain malignancies which include myelodysplastic syndromes, myeloid leukemia and squamous cell carcinomas of the upper aerodigestive tract. The Telomere Clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides multi-disciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include individuals with cancer, bone marrow failure/aplastic anemia, lung disease including idiopathic pulmonary fibrosis and liver cirrhosis, among others. Our clinic brings together geneticists, genetic counselors, and we work closely with expert physicians in adult and pediatric hematology, bone marrow transplant, pulmonary medicine, lung transplant medicine, hepatology, and otolaryngology. Together, our team has established expertise in the management of these disorders and is at the forefront of leading the effort to individualize care for affected patients and their families. My group also has ongoing research efforts which include a long-term study to understand the genetics and spectrum of telomere disorders through a Registry which has been based at Johns Hopkins since 2005.
Dr. Armanios is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Pulmonary Fibrosis, Primary T Cell Immunodeficiency, Emphysema, and Ataxia-Telangiectasia.
Her clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Hemolytic Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
1800 Orleans Street, Baltimore, MD 21287
4940 Eastern Avenue, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.
Children's National Hospital
Robert Nickel is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Nickel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.
Children's National Hospital
Jennifer Webb is a Hematologist and an Oncologist in Silver Spring, Maryland. Dr. Webb is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pulmonary FibrosisDr. Armanios isDistinguished. Learn about Pulmonary Fibrosis.
- Advanced
- Primary T Cell ImmunodeficiencyDr. Armanios isAdvanced. Learn about Primary T Cell Immunodeficiency.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Armanios isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Ataxia-TelangiectasiaDr. Armanios isExperienced. Learn about Ataxia-Telangiectasia.
- EmphysemaDr. Armanios isExperienced. Learn about Emphysema.
- Hemolytic AnemiaDr. Armanios isExperienced. Learn about Hemolytic Anemia.
- LeukemiaDr. Armanios isExperienced. Learn about Leukemia.
- Li-Fraumeni SyndromeDr. Armanios isExperienced. Learn about Li-Fraumeni Syndrome.
